Form 8-K - Current report:
SEC Accession No. 0001144204-14-066219
Filing Date
2014-11-10
Accepted
2014-11-10 08:02:42
Documents
3
Period of Report
2014-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v393584_8k.htm 8-K 14085
2 PRESS RELEASE v393584_ex99-1.htm EX-99.1 66484
3 GRAPHIC logo.jpg GRAPHIC 10422
  Complete submission text file 0001144204-14-066219.txt   96261
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 141206617
SIC: 2834 Pharmaceutical Preparations